Molecular pathogenesis of secondary hyperparathyroidism in renal failure: Basic and clinical aspects

Nephrology Dialysis Transplantation

Volumn 14, Issue SUPPL. 1, 1999, Pages 61-62

  Fukagawa, M ^a,b   Iwasaki, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL;

CLINICAL FEATURE; CONFERENCE PAPER; KIDNEY FAILURE; PARATHYROID HYPERPLASIA; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0032892709     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.suppl_1.61     Document Type: Conference Paper

References (19)

1. Malluche H, Faugere MC. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211
2. Coburn JW, Llach F. Renal osteodystrophy. In: Clinical disorders of fluid and electrolyte metabolism, 5th edn. Narins RG, ed. McGraw Hill, New York, 1994: 1299-1377
3. Akizawa T, Fukagawa M, Koshikawa S, Kurokawa K. Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Curr Opin Nephrol Hypertens 1993; 2: 558-565
4. Slatopolsky EA, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
5. Fukagawa M, Fukuda N, Yi H, Kurokawa K. Resistance to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 1995; 10: 316-319
6. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 1987; 316: 1573-1577
7. 3 in the parathyroid in vivo. J Clin Invest 1990; 86: 1968-1975
8. Patel SR, Ke H-Q, Vanholder R, Koenig RJ, Hsu CH. Inhibition of calcitriol receptor binding to vitamin D responsive elements by uremic toxins. J Clin Invest 1995; 96: 50-59
9. Sawaya BP, Koszewski NJ, Qi Q, Langub MC, Monier-Faugere M, Malluche HH. Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D responsive elements in rats with incipient renal failure. J Am Soc Nephrol 1997; 8: 271-278
10. Drücke TB. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 1995; 48: 259-272
11. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E, Kurokawa, K. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-228
12. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
13. Koike T, Fukuda N, Fukagawa M, Ohta K, Kurokawa K. Correlation of enhanced cell proliferation with decreased density of vitamin D receptor in situ in parathyroid hyperplasia in chronic dialysis patients. Nephrology 1997; 3: 279-284
14. Tominaga Y, Takagi H. Histology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997; 13: 78-86
15. Giangrande A, Castiglioni A, Sorbiati L, Allaria P. Ultrasound guided percutaneous fine needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992; 7: 412-421
16. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994; 46: 1110-1117
17. Fukagawa M, Kitaoka M, Kurokawa K. Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management. Kidney Int 1997; 52 [Suppl 62]: S60-S64
18. Kitaoka M, Fukagawa M, Kurokawa K. Direct injection of calcitriol into parathyroid hyperplasia in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology 1995; 1: 563-568
19. Fukuda N, Katoh T, Yi H, Fukagawa M, Saito I, Kanegae Y, Chang H, Kurokawa K. Successful in vivo gene transfer into parathyroid glands with adenoviral vector delivered by selective injection in rats. J Am Soc Nephrol 1995; 6: 961 [abstract]